Emerson Elec Co - EMR STOCK NEWS

Emerson (NYSE: EMR) has announced its upcoming second quarter 2025 earnings release and conference call schedule. The company will release its financial results before the market opens on Wednesday, May 7, 2025. Senior management will host an investor conference call at 8:00 a.m. Eastern Time (7:00 a.m. Central Time) on the same day.

Interested parties can access the live conference call and presentation slides through Emerson's website in the Investors section at www.Emerson.com/investors after completing a registration form. The conference call recording will remain available for three months following the webcast at the same location.

Emerson (NYSE: EMR) announced its annual NI Connect conference, scheduled for April 28-30, 2024, at the Fort Worth Convention Center in Texas. The conference will showcase advancements in test and measurement technology, featuring keynote presentations from industry leaders.

Notable speakers include:

• Archer Aviation's Director Tramone Curry discussing eVTOL aircraft validation
• Milwaukee Tool's Beth Heath presenting on 24/7 tool life testing
• Qualcomm's engineers highlighting PXI-based test platforms for RF and PMIC devices
• UT's Jamie Huffman sharing insights on rocket engineering with LabVIEW

The event will feature over 90 expert-led sessions, focusing on platform innovations, workflow optimization, and comprehensive ecosystems. Attendees will have access to new product announcements for NI DAQ, LabVIEW, PXI, and hands-on demonstrations including early AI integrations.

Emerson (NYSE: EMR) has successfully completed the acquisition of all remaining outstanding shares of AspenTech not previously owned, marking a significant milestone in Emerson's portfolio transformation. The tender offer expired on March 11, 2025, with shareholders receiving $265.00 per share in cash.

The tender offer resulted in approximately 19.5 million shares being validly tendered, representing about 72% of AspenTech's outstanding shares not already owned by Emerson. Following the tender offer completion, AspenTech has become a wholly owned subsidiary of Emerson and its shares have ceased trading on NASDAQ.

Key leadership changes include Antonio Pietri's retirement as AspenTech CEO, with Vincent M. Servello appointed as President of the AspenTech business unit. AspenTech will operate as an independent business unit, with its results being consolidated into Emerson's Control Systems & Software segment.

Emerson (NYSE: EMR) has extended its tender offer deadline to acquire remaining Aspen Technology (NASDAQ: AZPN) shares to March 11, 2025, at 5:00 p.m. Eastern Time. The extension accommodates the settlement and tendering of shares due to AspenTech's removal from the S&P MidCap 400 index, effective March 11, 2025.

The tender offer maintains its $265 per share price, which Emerson has stated is its best and final offer. As of March 7, 2025, approximately 6,715,211 shares had been validly tendered and not withdrawn. Previously tendered shares require no additional action from holders.

Emerson (NYSE: EMR) and Zitara Technologies have announced a strategic partnership to enhance battery management solutions. The collaboration will integrate Zitara's advanced battery energy storage systems software into Emerson's Ovation™ automation platform, offering improved battery performance and monitoring capabilities.

The integration aims to provide enhanced energy storage management, optimized battery usage, and improved battery lifetime and safety across various applications. The partnership builds on Emerson's existing investment in Zitara through Emerson Ventures and will help utilities meet increasing demands for reliable, affordable, and sustainable power and water.

The enhanced Ovation platform will help power operators manage distributed energy resources using real-time data for improved load and demand management, while incorporating Zitara's advanced battery monitoring and controls solutions.

Elliott Investment Management, managing funds with over $1.5 billion investment in Aspen Technology (NASDAQ: AZPN), has issued a statement criticizing Emerson Electric's tender offer for remaining AspenTech shares. Elliott strongly opposes the acquisition attempt, characterizing it as a conflicted and deeply flawed process that resembles an opportunistic minority squeeze-out.

The investment firm argues that Emerson's public statements and actions leading to the tender offer demonstrate coercive intent toward minority stockholders. Elliott has declared the transaction unfair and plans to pursue all appropriate remedies against Emerson.

Emerson (NYSE: EMR) has responded to Elliott Investment Management's statement regarding its tender offer to acquire all outstanding shares of AspenTech (NASDAQ: AZPN) not already owned by Emerson. The offer stands at $265 per share in cash, representing Emerson's best and final price following three months of negotiations with AspenTech's Special Committee.

The offer, set to expire on March 10, 2025, requires a majority of minority shares to be tendered for completion. The AspenTech Special Committee, comprising three independent directors, unanimously recommends the transaction as superior to AspenTech's standalone prospects. If the tender offer expires without meeting the majority condition, Emerson will maintain its existing majority ownership stake in AspenTech, which would remain a publicly-traded controlled company.

Elliott Investment Management, managing funds with over $1.5 billion investment in Aspen Technology (NASDAQ: AZPN), has publicly opposed the recently announced tender offer by Emerson Electric Co. (NYSE: EMR). Emerson, AspenTech's majority stockholder, proposed to acquire the remaining shares it doesn't own at $265.00 per share.

As AspenTech's largest minority investor, Elliott stated that Emerson's offer is highly opportunistic and substantially undervalues the company. The investment firm has declared it will not tender its shares at the current price.

Emerson (NYSE: EMR) reported strong Q1 2025 results with net sales reaching $4,175 million, up 1% from the previous year. The company demonstrated significant improvements in profitability, with pretax earnings margin expanding to 18.6% from 4.2% year-over-year. Adjusted earnings per share increased 13% to $1.38, while operating cash flow grew 75% to $777 million.

The company updated its fiscal 2025 outlook, projecting net sales growth of 1.5-3.5% and underlying sales growth of 3-5%. Emerson plans to return approximately $3.2 billion to shareholders through $2.0 billion in share repurchases and $1.2 billion in dividend payments. The company declared a quarterly dividend of $0.5275 per share, payable March 10, 2025.